NASDAQ: ZYMEZymeworks Inc Stock Ownership - Who owns Zymeworks?
Insider buying vs selling
Have Zymeworks Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Paul Andrew Moore | Chief Scientific Officer | 2024-01-08 | 2,339 | $11.22 | $26.23kSell |
| Kenneth Galbraith | Chair CEO | 2024-01-08 | 5,706 | $11.22 | $64.00kSell |
| Christopher Astle | SVP Chief Financial Officer | 2024-01-08 | 1,431 | $11.22 | $16.05kSell |
| Kenneth Galbraith | Chair CEO | 2024-01-05 | 18,198 | $10.65 | $193.85kSell |
| Christopher Astle | SVP Chief Financial Officer | 2024-01-05 | 4,563 | $10.65 | $48.61kSell |
| Paul Andrew Moore | Chief Scientific Officer | 2024-01-05 | 7,460 | $10.65 | $79.46kSell |
| Christopher Astle | SVP Chief Financial Officer | 2023-12-11 | 886 | $9.13 | $8.09kSell |
| Ecor1 Capital LLC | 10% Owner | 2023-06-16 | 3,350,000 | $8.12 | $27.20MBuy |
ZYME insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ZYME insiders and whales buy or sell their stock.
ZYME Shareholders
What type of owners hold Zymeworks Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ecor1 Capital LLC | 43.78% | 30,893,519 | $264.45M | Insider |
| Ecor1 Capital LLC | 19.04% | 13,437,473 | $115.02M | Institution |
| Redmile Group LLC | 8.57% | 6,045,437 | $51.75M | Insider |
| Bvf Inc | 8.32% | 5,870,000 | $50.25M | Institution |
| Redmile Group LLC | 8.21% | 5,790,230 | $49.56M | Institution |
| Morgan Stanley | 6.89% | 4,861,286 | $41.61M | Institution |
| Blackrock Inc | 5.56% | 3,923,328 | $33.58M | Institution |
| Rubric Capital Management LP | 4.92% | 3,475,384 | $29.75M | Institution |
| Vanguard Group Inc | 3.39% | 2,394,712 | $20.50M | Institution |
| Credit Suisse Ag 1 | 3.26% | 2,303,621 | $19.72M | Institution |
ZYME vs Biotech Stocks
Zymeworks Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.